B, Y., R, G., R, A., S, A., N, S., J, A., . . . Y, A. (2026). Consensus Recommendations for the Diagnosis and Treatment of Neuromyelitis Optica Spectrum Disorders (NMOSD): The MENACTRIMS Guidelines. CNS drugs, 40(3), 283. https://doi.org/10.1007/s40263-025-01260-x
Chicago Style (17th ed.) CitationB, Yamout, et al. "Consensus Recommendations for the Diagnosis and Treatment of Neuromyelitis Optica Spectrum Disorders (NMOSD): The MENACTRIMS Guidelines." CNS Drugs 40, no. 3 (2026): 283. https://doi.org/10.1007/s40263-025-01260-x.
MLA (9th ed.) CitationB, Yamout, et al. "Consensus Recommendations for the Diagnosis and Treatment of Neuromyelitis Optica Spectrum Disorders (NMOSD): The MENACTRIMS Guidelines." CNS Drugs, vol. 40, no. 3, 2026, p. 283, https://doi.org/10.1007/s40263-025-01260-x.